PLTK vs. HQY, STN, BILI, GLOB, WSC, ETSY, LYFT, QXO, RELY, and AMTM
Should you be buying Playtika stock or one of its competitors? The main competitors of Playtika include HealthEquity (HQY), Stantec (STN), Bilibili (BILI), Globant (GLOB), WillScot Mobile Mini (WSC), Etsy (ETSY), Lyft (LYFT), QXO (QXO), Remitly Global (RELY), and Amentum (AMTM). These companies are all part of the "business services" industry.
Playtika vs.
HealthEquity (NASDAQ:HQY) and Playtika (NASDAQ:PLTK) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, earnings, risk, profitability, institutional ownership, dividends, valuation and community ranking.
HealthEquity has a beta of 0.55, suggesting that its stock price is 45% less volatile than the S&P 500. Comparatively, Playtika has a beta of 0.92, suggesting that its stock price is 8% less volatile than the S&P 500.
HealthEquity received 486 more outperform votes than Playtika when rated by MarketBeat users. Likewise, 70.12% of users gave HealthEquity an outperform vote while only 45.37% of users gave Playtika an outperform vote.
Playtika has higher revenue and earnings than HealthEquity. Playtika is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
99.6% of HealthEquity shares are held by institutional investors. Comparatively, 11.9% of Playtika shares are held by institutional investors. 2.2% of HealthEquity shares are held by company insiders. Comparatively, 4.8% of Playtika shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Playtika has a net margin of 8.52% compared to HealthEquity's net margin of 8.41%. HealthEquity's return on equity of 9.70% beat Playtika's return on equity.
HealthEquity currently has a consensus price target of $113.54, suggesting a potential upside of 8.32%. Playtika has a consensus price target of $8.21, suggesting a potential upside of 61.26%. Given Playtika's higher probable upside, analysts clearly believe Playtika is more favorable than HealthEquity.
In the previous week, Playtika had 37 more articles in the media than HealthEquity. MarketBeat recorded 55 mentions for Playtika and 18 mentions for HealthEquity. HealthEquity's average media sentiment score of 0.87 beat Playtika's score of 0.27 indicating that HealthEquity is being referred to more favorably in the media.
Summary
HealthEquity beats Playtika on 10 of the 18 factors compared between the two stocks.
Get Playtika News Delivered to You Automatically
Sign up to receive the latest news and ratings for PLTK and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Playtika Competitors List
Related Companies and Tools
This page (NASDAQ:PLTK) was last updated on 3/4/2025 by MarketBeat.com Staff
Free PLTK Stock Alerts